Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 2.9% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price was down 2.9% on Wednesday . The company traded as low as $43.01 and last traded at $43.07. Approximately 515,229 shares changed hands during trading, a decline of 74% from the average daily volume of 2,003,954 shares. The stock had previously closed at $44.37.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ACHC shares. Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective for the company in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price objective for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Trading Down 2.5 %

The business has a 50 day simple moving average of $40.64 and a 200-day simple moving average of $57.36. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a market capitalization of $3.90 billion, a P/E ratio of 13.75, a price-to-earnings-growth ratio of 1.81 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue was up 8.7% compared to the same quarter last year. During the same period last year, the company posted $0.91 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently modified their holdings of the stock. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after acquiring an additional 241 shares in the last quarter. Commonwealth Equity Services LLC boosted its stake in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after acquiring an additional 257 shares in the last quarter. Atria Investments Inc boosted its stake in shares of Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock worth $434,000 after acquiring an additional 308 shares in the last quarter. KBC Group NV lifted its holdings in shares of Acadia Healthcare by 14.4% in the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after purchasing an additional 338 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in shares of Acadia Healthcare by 7.9% in the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after purchasing an additional 340 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.